Cargando…

Immunotherapy for bladder cancer

It is nearly 40 years since Bacillus Calmette–Guérin (BCG) was first used as an immunotherapy to treat superficial bladder cancer. Despite its limitations, to date it has not been surpassed by any other treatment. As a better understanding of its mechanism of action and the clinical response to it h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuge, Oliver, Vasdev, Nikhil, Allchorne, Paula, Green, James SA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427258/ https://www.ncbi.nlm.nih.gov/pubmed/26000263 http://dx.doi.org/10.2147/RRU.S63447

Ejemplares similares

Biomarkers in Bladder Cancer Surveillance
por: Sugeeta, Sukumar S., et al.
Publicado: (2021)

Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer
por: Chhaya, Saachi, et al.
Publicado: (2023)

Methods of Sentinel Lymph Node Detection and Management in Urinary Bladder Cancer—A Narrative Review
por: Sinha, Ankit, et al.
Publicado: (2022)

Review of the evidence for robotic-assisted robotic cystectomy and intra-corporeal urinary diversion in bladder cancer
por: Brodie, Andrew, et al.
Publicado: (2020)

BCG in Bladder Cancer Immunotherapy
por: Jiang, Song, et al.
Publicado: (2022)

The surgical management of the refractory overactive bladder
por: Vasdev, Nikhil, et al.
Publicado: (2010)

T1G3 bladder cancer, bacillus Calmette-Guerin and radical cystectomy: continued debate
por: Brodie, Andrew, et al.
Publicado: (2018)

Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era
por: Ng, Kenrick, et al.
Publicado: (2020)

Bladder Cancer Immunotherapy: BCG and Beyond
por: Askeland, Eric J., et al.
Publicado: (2012)

Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer
por: Peyrottes, Arthur, et al.
Publicado: (2021)

Is it oncologically and clinically safe to adopt a bladder sparing approach in complete responders following neoadjuvant chemotherapy alone without proceeding to a radical cystectomy?
por: Arianayagam, Ranjan, et al.
Publicado: (2018)

Blue light transurethral resection and biopsy of bladder cancer with hexaminolevulinate: Histopathological characteristics and recurrence rates in a single UK centre study
por: Chan, Kimberley, et al.
Publicado: (2023)

Intravesical immunotherapy in nonmuscle invasive bladder cancer
por: Jokisch, Jan-Friedrich, et al.
Publicado: (2015)

Nonmuscle invasive bladder cancer: a primer on immunotherapy
por: Maruf, Mahir, et al.
Publicado: (2016)

Biomarkers for immunotherapy in bladder cancer: a moving target
por: Aggen, David H., et al.
Publicado: (2017)

Immunotherapy in Bladder Cancer: Current Methods and Future Perspectives
por: Wołącewicz, Mikołaj, et al.
Publicado: (2020)

Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
por: Scholtes, Mathijs P., et al.
Publicado: (2021)

Perioperative immunotherapy in muscle-invasive bladder cancer
por: Lee, Hyung Ho, et al.
Publicado: (2020)

Immune escape mechanisms and immunotherapy of urothelial bladder cancer
por: Yang, Zhao, et al.
Publicado: (2021)

Perioperative immunotherapy for muscle-invasive bladder cancer
por: Kim, In-Ho, et al.
Publicado: (2020)

The impact of early re-resection in patients with pT1 high-grade non-muscle invasive bladder cancer
por: Vasdev, Nikhil, et al.
Publicado: (2012)

Immunotherapy and Radiation – A New Combined Treatment Approach for Bladder Cancer?
por: Buchwald, Zachary S., et al.
Publicado: (2015)

Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer
por: Benjamin, David J., et al.
Publicado: (2021)

Secondary neoplasms of the urinary bladder-clinical management and oncological outcomes
por: El-Taji, Omar, et al.
Publicado: (2021)

Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches
por: Song, Dongkui, et al.
Publicado: (2019)

Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
por: Kamat, Ashish M., et al.
Publicado: (2017)

The experience of UK patients with bladder cancer during the second wave of the COVID‐19 pandemic
por: Russell, Beth, et al.
Publicado: (2022)

Combining Antiandrogens with Immunotherapy for Bladder Cancer Treatment
por: Besançon, Marjorie, et al.
Publicado: (2022)

The Liver–Immunity Nexus and Cancer Immunotherapy
por: Lee, James C., et al.
Publicado: (2022)

Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer
por: Semeniuk-Wojtaś, Aleksandra, et al.
Publicado: (2023)

Molecular Markers in Urinary Bladder Cancer: Applications for Diagnosis, Prognosis and Therapy
por: Rasteiro, Ana Mafalda, et al.
Publicado: (2022)

Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
por: Kamat, Ashish M., et al.
Publicado: (2017)

Bladder rupture after pembrolizumab immunotherapy for bladder cancer: a case report
por: Badheeb, Ahmed, et al.
Publicado: (2022)

The experience of UK patients with bladder cancer during the COVID‐19 pandemic: a survey‐based snapshot
por: Spencer‐Bowdage, Sarah, et al.
Publicado: (2020)

Tumor-Associated Macrophages in Bladder Cancer: Biological Role, Impact on Therapeutic Response and Perspectives for Immunotherapy
por: Leblond, Marine M., et al.
Publicado: (2021)

Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer
por: Shukla, Nikhil, et al.
Publicado: (2021)

Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guérin for Bladder Cancer
por: Liu, Yuqing, et al.
Publicado: (2019)

Immunotherapy: a new treatment paradigm in bladder cancer
por: Davarpanah, Nicole N., et al.
Publicado: (2017)

Identification of an immunotherapy-responsive molecular subtype of bladder cancer
por: Song, Bic-Na, et al.
Publicado: (2019)

Prevention and Treatment of Side Effects of Immunotherapy for Bladder Cancer
por: Lou, Kecheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_io08l7cqvc2ps4q2f3b5abcqub